NCT00953407

Brief Summary

The purpose of this trial is to evaluate the extent to which symptoms improve in symptomatic contact lens wearers when fit with one of 5 different daily disposable contact lenses.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2009

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 8, 2009

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 6, 2009

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

November 1, 2010

Completed
Last Updated

July 10, 2012

Status Verified

January 1, 2012

Enrollment Period

2 months

First QC Date

July 8, 2009

Results QC Date

September 16, 2010

Last Update Submit

June 26, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lens Awareness

    Lens awareness, as interpreted by the subject, was reported by the subject as a single, retrospective evaluation of 4 week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being all the time. Four-week ratings were compared to baseline ratings, and a negative difference (4-week minus baseline) represented an improvement.

    4 weeks of wear

Study Arms (5)

Nelfilcon A

EXPERIMENTAL

Nelfilcon A contact lens

Device: Nelfilcon A contact lens

Narafilcon A

ACTIVE COMPARATOR

Narafilcon A contact lens

Device: Narafilcon A contact lens

Etafilcon A

ACTIVE COMPARATOR

Etafilcon A contact lens

Device: Etafilcon A contact lens

Omafilcon A

ACTIVE COMPARATOR

Omafilcon A contact lens

Device: Omafilcon A contact lens

Hilafilcon B

ACTIVE COMPARATOR

Hilafilcon B contact lens

Device: Hilafilcon B contact lens

Interventions

Daily disposable contact lens worn in a daily wear, daily disposable mode

Nelfilcon A

Daily disposable contact lens worn in a daily wear, daily disposable mode

Narafilcon A

Daily disposable contact lens worn in a daily wear, daily disposable mode

Etafilcon A

Daily disposable contact lens worn in a daily wear, daily disposable mode

Omafilcon A

Daily disposable contact lens worn in a daily wear, daily disposable mode

Hilafilcon B

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Currently wear spherical, soft contact lenses replaced at intervals of 2 weeks or monthly.
  • Habitually wear lenses for at least 8 hours per day, 4 days per week, for at least the past 6 months.
  • Report 2 or more qualifying symptoms with current contact lenses with a frequency of "frequently" or "all the time"
  • Able to achieve VA of at least 20/40 in each eye with habitual correction and with study lenses at dispense.

You may not qualify if:

  • Eye injury or surgery within twelve weeks immediately prior to enrollment.
  • Currently enrolled in any clinical trial.
  • Any use of medications for which contact lens wear could be contraindicated as determined by the investigator.
  • History of corneal refractive surgery.
  • Cylinder correction greater than 1.00 D.
  • Current monovision contact lens wearers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs
Organization
CIBA VISION

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2009

First Posted

August 6, 2009

Study Start

July 1, 2009

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

July 10, 2012

Results First Posted

November 1, 2010

Record last verified: 2012-01